Sigachi Industries Limited (SIGACHI.BO)
INR 52.77
(2.73%)
INR 52.77
(2.73%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 6.94 Billion INR | 85.73% |
| 2022 | 3.73 Billion INR | 30.32% |
| 2021 | 2.86 Billion INR | 114.98% |
| 2020 | 1.33 Billion INR | 22.23% |
| 2019 | 1.09 Billion INR | 19.33% |
| 2018 | 914.62 Million INR | 26.52% |
| 2017 | 722.88 Million INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 6.37 Billion INR | 0.0% |
| 2023 FY | 6.94 Billion INR | 85.73% |
| 2023 Q4 | 6.94 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 FY | 3.73 Billion INR | 30.32% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 3.52 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 3.73 Billion INR | 0.0% |
| 2021 Q1 | 1.51 Billion INR | 13.5% |
| 2021 FY | 2.86 Billion INR | 114.98% |
| 2021 Q4 | 2.86 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 1.7 Billion INR | 12.29% |
| 2020 Q4 | 1.33 Billion INR | 0.0% |
| 2020 FY | 1.33 Billion INR | 22.23% |
| 2020 Q1 | - INR | 0.0% |
| 2019 FY | 1.09 Billion INR | 19.33% |
| 2018 FY | 914.62 Million INR | 26.52% |
| 2017 FY | 722.88 Million INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Ajanta Pharma Limited | 46.38 Billion INR | 85.035% |
| Amrutanjan Health Care Limited | 3.66 Billion INR | -89.21% |
| Bal Pharma Limited | 3.2 Billion INR | -116.661% |
| Ind-Swift Laboratories Limited | 11.65 Billion INR | 40.421% |
| Medico Remedies Limited | 961.95 Million INR | -621.612% |
| Lasa Supergenerics Limited | 1.5 Billion INR | -360.106% |
| Venus Remedies Limited | 6.26 Billion INR | -10.741% |
| Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | -34.777% |
| Alpa Laboratories Limited | 1.82 Billion INR | -280.106% |
| Nectar Lifesciences Limited | 21.91 Billion INR | 68.319% |
| Shilpa Medicare Limited | 30.93 Billion INR | 77.559% |
| Aarti Drugs Limited | 24.32 Billion INR | 71.462% |
| Lupin Limited | 239.97 Billion INR | 97.107% |
| Aurobindo Pharma Limited | 450.71 Billion INR | 98.46% |
| Zydus Lifesciences Limited | 292.8 Billion INR | 97.629% |
| Windlas Biotech Limited | 6.26 Billion INR | -10.851% |
| Suven Life Sciences Limited | 2.84 Billion INR | -143.647% |
| Eris Lifesciences Limited | 70.48 Billion INR | 90.152% |
| Valiant Laboratories Limited | 3.42 Billion INR | -102.563% |
| J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | 82.621% |
| Solara Active Pharma Sciences Limited | 23.5 Billion INR | 70.473% |
| Ipca Laboratories Limited | 111.01 Billion INR | 93.747% |
| Bliss GVS Pharma Limited | 12.13 Billion INR | 42.815% |
| Achyut Healthcare Limited | 309.52 Million INR | -2142.673% |
| Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 99.188% |
| Bajaj HealthCare Limited | 7.65 Billion INR | 9.276% |
| RPG Life Sciences Limited | 5.12 Billion INR | -35.347% |
| Mankind Pharma Limited | 119.63 Billion INR | 94.198% |
| Laurus Labs Limited | 83.87 Billion INR | 91.723% |
| Piramal Pharma Limited | 153.11 Billion INR | 95.467% |
| Syncom Formulations (India) Limited | 4.04 Billion INR | -71.539% |
| Torrent Pharmaceuticals Limited | 150.61 Billion INR | 95.391% |
| Alembic Pharmaceuticals Limited | 64.45 Billion INR | 89.231% |
| Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 95.166% |
| Unichem Laboratories Limited | 31.69 Billion INR | 78.098% |
| Sequent Scientific Limited | 15.4 Billion INR | 54.936% |
| Novartis India Limited | 9.24 Billion INR | 24.95% |
| Wanbury Limited | 3.43 Billion INR | -102.087% |
| Suven Pharmaceuticals Limited | 22.54 Billion INR | 69.205% |
| Wockhardt Limited | 76.49 Billion INR | 90.925% |
| Themis Medicare Limited | 5.66 Billion INR | -22.552% |
| Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -219.773% |
| Jubilant Pharmova Limited | 115.48 Billion INR | 93.989% |
| Glenmark Life Sciences Limited | 28.5 Billion INR | 75.647% |
| Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 98.209% |
| Divi's Laboratories Limited | 154.7 Billion INR | 95.513% |
| NATCO Pharma Limited | 69.06 Billion INR | 89.949% |
| Gufic Biosciences Limited | 10.92 Billion INR | 36.464% |
| IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | 69.072% |
| Ind-Swift Limited | 6.54 Billion INR | -6.064% |
| Procter & Gamble Health Limited | 7.94 Billion INR | 12.614% |
| FDC Limited | 24.68 Billion INR | 71.875% |
| Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -289.593% |
| Granules India Limited | 55.2 Billion INR | 87.427% |
| Medicamen Biotech Limited | 2.94 Billion INR | -135.689% |
| Alkem Laboratories Limited | 155.74 Billion INR | 95.543% |
| AstraZeneca Pharma India Limited | 10.78 Billion INR | 35.609% |
| Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -1374.335% |
| Brooks Laboratories Limited | 904.45 Million INR | -667.487% |
| Megasoft Limited | 3.65 Billion INR | -89.712% |
| ZIM Laboratories Limited | 4.46 Billion INR | -55.354% |
| Strides Pharma Science Limited | 58.39 Billion INR | 88.113% |
| Neuland Laboratories Limited | 18.32 Billion INR | 62.121% |
| Morepen Laboratories Limited | 12.93 Billion INR | 46.323% |
| Hikal Limited | 24.87 Billion INR | 72.09% |
| Indoco Remedies Limited | 21.44 Billion INR | 67.634% |
| Aarti Pharmalabs Limited | 25.82 Billion INR | 73.117% |
| Kilitch Drugs (India) Limited | 2.4 Billion INR | -189.158% |
| Mangalam Drugs & Organics Limited | 3.33 Billion INR | -108.19% |
| Hester Biosciences Limited | 6.62 Billion INR | -4.803% |